Delivery Order SPE2DB20D2104-SPE2DB24FS55R
- Not listed
- This federal contract award, valued at $2,118.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including...
- This federal contract award, valued at $3,767.78, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This federal contract award, valued at $2,313.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This federal contract award, valued at $4,455.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty pharmaceutical product, with a period of performance through November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $1,343.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a specialty medication, with an ultimate completion date of June 11, 2024. The contract is a firm fixed-price arrangement, and there is no set-aside designation mentioned. AmerisourceBergen holds a significant...
- This federal contract award, valued at $2,118.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. The contract has a firm fixed price and an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award, valued at $5,213.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication for diabetes management. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999.00 and runs through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $4,387.67, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medical products. The contract has an ultimate completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,731.39 fixed-price delivery order is for VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a pharmaceutical product, with a completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.12 fixed-price delivery order is for the procurement of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS55RDelivery Order
This federal contract award, valued at $3,359.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VICTOZA 2-PAK 18 MG/3 ML PEN 3ML, a specialty pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a comprehensive vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 2/13/24 |